nodes	percent_of_prediction	percent_of_DWPC	metapath
Chlorpropamide—Sulfacetamide—Dapsone—systemic lupus erythematosus	0.308	1	CrCrCtD
Chlorpropamide—PTGS1—Dapsone—systemic lupus erythematosus	0.0706	0.141	CbGbCtD
Chlorpropamide—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.0407	0.0811	CbGbCtD
Chlorpropamide—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0399	0.0795	CbGbCtD
Chlorpropamide—CYP2C19—Dapsone—systemic lupus erythematosus	0.0342	0.0682	CbGbCtD
Chlorpropamide—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0316	0.0629	CbGbCtD
Chlorpropamide—CYP2C9—Dapsone—systemic lupus erythematosus	0.0284	0.0567	CbGbCtD
Chlorpropamide—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0239	0.0477	CbGbCtD
Chlorpropamide—CYP2C19—Prednisone—systemic lupus erythematosus	0.0237	0.0473	CbGbCtD
Chlorpropamide—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0225	0.0448	CbGbCtD
Chlorpropamide—SLC22A6—Methotrexate—systemic lupus erythematosus	0.0215	0.0429	CbGbCtD
Chlorpropamide—ABCB1—Betamethasone—systemic lupus erythematosus	0.0205	0.0409	CbGbCtD
Chlorpropamide—ABCB1—Prednisolone—systemic lupus erythematosus	0.0202	0.0404	CbGbCtD
Chlorpropamide—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0192	0.0383	CbGbCtD
Chlorpropamide—ABCB1—Prednisone—systemic lupus erythematosus	0.0191	0.0381	CbGbCtD
Chlorpropamide—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0187	0.0372	CbGbCtD
Chlorpropamide—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0181	0.0361	CbGbCtD
Chlorpropamide—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0148	0.0295	CbGbCtD
Chlorpropamide—SLC15A2—choroid plexus—systemic lupus erythematosus	0.0144	0.213	CbGeAlD
Chlorpropamide—CYP2C9—cardial valve—systemic lupus erythematosus	0.0134	0.198	CbGeAlD
Chlorpropamide—SLC15A2—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.0126	0.269	CbGpPWpGaD
Chlorpropamide—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0123	0.0245	CbGbCtD
Chlorpropamide—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0119	0.0238	CbGbCtD
Chlorpropamide—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A4—systemic lupus erythematosus	0.0117	0.25	CbGpPWpGaD
Chlorpropamide—ABCB1—Methotrexate—systemic lupus erythematosus	0.00959	0.0191	CbGbCtD
Chlorpropamide—CYP2C19—urine—systemic lupus erythematosus	0.00373	0.055	CbGeAlD
Chlorpropamide—Water retention—Hydrocortisone—systemic lupus erythematosus	0.00339	0.0473	CcSEcCtD
Chlorpropamide—Proctocolitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00335	0.0466	CcSEcCtD
Chlorpropamide—Water retention—Dexamethasone—systemic lupus erythematosus	0.0029	0.0404	CcSEcCtD
Chlorpropamide—Water retention—Betamethasone—systemic lupus erythematosus	0.0029	0.0404	CcSEcCtD
Chlorpropamide—CYP2C9—urine—systemic lupus erythematosus	0.00289	0.0426	CbGeAlD
Chlorpropamide—Water retention—Prednisone—systemic lupus erythematosus	0.00253	0.0352	CcSEcCtD
Chlorpropamide—SLC22A6—nephron tubule—systemic lupus erythematosus	0.002	0.0295	CbGeAlD
Chlorpropamide—CYP2C19—blood plasma—systemic lupus erythematosus	0.00194	0.0287	CbGeAlD
Chlorpropamide—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.00171	0.0252	CbGeAlD
Chlorpropamide—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.0017	0.0362	CbGpPWpGaD
Chlorpropamide—Digestion impaired—Leflunomide—systemic lupus erythematosus	0.00168	0.0234	CcSEcCtD
Chlorpropamide—SLC15A1—nephron tubule—systemic lupus erythematosus	0.00166	0.0245	CbGeAlD
Chlorpropamide—Gliclazide—VEGFA—systemic lupus erythematosus	0.0016	0.425	CrCbGaD
Chlorpropamide—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A4—systemic lupus erythematosus	0.00158	0.0336	CbGpPWpGaD
Chlorpropamide—PTGS1—endothelium—systemic lupus erythematosus	0.00155	0.0229	CbGeAlD
Chlorpropamide—ABCC8—kidney—systemic lupus erythematosus	0.00153	0.0225	CbGeAlD
Chlorpropamide—CYP2C9—blood plasma—systemic lupus erythematosus	0.00151	0.0222	CbGeAlD
Chlorpropamide—SLC15A1—kidney—systemic lupus erythematosus	0.00146	0.0216	CbGeAlD
Chlorpropamide—KCNJ11—lymphoid tissue—systemic lupus erythematosus	0.00143	0.021	CbGeAlD
Chlorpropamide—PTGS1—Prostaglandin Synthesis and Regulation—ANXA3—systemic lupus erythematosus	0.0014	0.0299	CbGpPWpGaD
Chlorpropamide—PTGS1—blood plasma—systemic lupus erythematosus	0.00138	0.0203	CbGeAlD
Chlorpropamide—Jaundice cholestatic—Azathioprine—systemic lupus erythematosus	0.00135	0.0189	CcSEcCtD
Chlorpropamide—KCNJ11—tendon—systemic lupus erythematosus	0.00134	0.0198	CbGeAlD
Chlorpropamide—Digestion impaired—Cyclosporine—systemic lupus erythematosus	0.0013	0.0181	CcSEcCtD
Chlorpropamide—Eruption—Hydrocortisone—systemic lupus erythematosus	0.00125	0.0174	CcSEcCtD
Chlorpropamide—Glipizide—PPARG—systemic lupus erythematosus	0.00123	0.327	CrCbGaD
Chlorpropamide—Photosensitivity reaction—Dapsone—systemic lupus erythematosus	0.00121	0.0168	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Azathioprine—systemic lupus erythematosus	0.00112	0.0156	CcSEcCtD
Chlorpropamide—KCNJ11—nervous system—systemic lupus erythematosus	0.00109	0.0161	CbGeAlD
Chlorpropamide—KCNJ11—central nervous system—systemic lupus erythematosus	0.00105	0.0155	CbGeAlD
Chlorpropamide—SLC15A2—nephron tubule—systemic lupus erythematosus	0.00104	0.0153	CbGeAlD
Chlorpropamide—KCNJ11—Type II diabetes mellitus—ADIPOQ—systemic lupus erythematosus	0.00103	0.022	CbGpPWpGaD
Chlorpropamide—ABCC8—nervous system—systemic lupus erythematosus	0.001	0.0148	CbGeAlD
Chlorpropamide—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.001	0.0213	CbGpPWpGaD
Chlorpropamide—ABCC8—central nervous system—systemic lupus erythematosus	0.000965	0.0142	CbGeAlD
Chlorpropamide—Jaundice cholestatic—Mycophenolate mofetil—systemic lupus erythematosus	0.000963	0.0134	CcSEcCtD
Chlorpropamide—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A4—systemic lupus erythematosus	0.00093	0.0198	CbGpPWpGaD
Chlorpropamide—SLC15A2—kidney—systemic lupus erythematosus	0.000913	0.0135	CbGeAlD
Chlorpropamide—SLC15A2—cortex of kidney—systemic lupus erythematosus	0.00089	0.0131	CbGeAlD
Chlorpropamide—Fluid retention—Cyclosporine—systemic lupus erythematosus	0.000823	0.0115	CcSEcCtD
Chlorpropamide—ABCB1—blood plasma—systemic lupus erythematosus	0.000814	0.012	CbGeAlD
Chlorpropamide—Fluid retention—Mycophenolate mofetil—systemic lupus erythematosus	0.000803	0.0112	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000794	0.0111	CcSEcCtD
Chlorpropamide—Eruption—Methotrexate—systemic lupus erythematosus	0.000779	0.0109	CcSEcCtD
Chlorpropamide—Fluid retention—Prednisolone—systemic lupus erythematosus	0.000749	0.0104	CcSEcCtD
Chlorpropamide—PTGS1—connective tissue—systemic lupus erythematosus	0.000733	0.0108	CbGeAlD
Chlorpropamide—Fluid retention—Hydrocortisone—systemic lupus erythematosus	0.000732	0.0102	CcSEcCtD
Chlorpropamide—Pancytopenia—Azathioprine—systemic lupus erythematosus	0.000709	0.00987	CcSEcCtD
Chlorpropamide—Eosinophilia—Leflunomide—systemic lupus erythematosus	0.000698	0.00972	CcSEcCtD
Chlorpropamide—Fluid retention—Triamcinolone—systemic lupus erythematosus	0.000689	0.0096	CcSEcCtD
Chlorpropamide—Fluid retention—Methylprednisolone—systemic lupus erythematosus	0.000687	0.00957	CcSEcCtD
Chlorpropamide—Haemolytic anaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.00068	0.00947	CcSEcCtD
Chlorpropamide—Pancytopenia—Leflunomide—systemic lupus erythematosus	0.000669	0.00932	CcSEcCtD
Chlorpropamide—PTGS1—skin of body—systemic lupus erythematosus	0.000662	0.00976	CbGeAlD
Chlorpropamide—SLC15A2—lung—systemic lupus erythematosus	0.000647	0.00955	CbGeAlD
Chlorpropamide—Hypoglycaemia—Cyclosporine—systemic lupus erythematosus	0.000645	0.00898	CcSEcCtD
Chlorpropamide—Hypoglycaemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000629	0.00876	CcSEcCtD
Chlorpropamide—Fluid retention—Dexamethasone—systemic lupus erythematosus	0.000625	0.00871	CcSEcCtD
Chlorpropamide—Fluid retention—Betamethasone—systemic lupus erythematosus	0.000625	0.00871	CcSEcCtD
Chlorpropamide—PTGS1—kidney—systemic lupus erythematosus	0.000624	0.0092	CbGeAlD
Chlorpropamide—Agranulocytosis—Azathioprine—systemic lupus erythematosus	0.000621	0.00865	CcSEcCtD
Chlorpropamide—Hyponatraemia—Mycophenolate mofetil—systemic lupus erythematosus	0.000617	0.00859	CcSEcCtD
Chlorpropamide—SLC15A2—nervous system—systemic lupus erythematosus	0.000599	0.00884	CbGeAlD
Chlorpropamide—Agranulocytosis—Leflunomide—systemic lupus erythematosus	0.000587	0.00817	CcSEcCtD
Chlorpropamide—SLC15A2—central nervous system—systemic lupus erythematosus	0.000577	0.00851	CbGeAlD
Chlorpropamide—Erythema multiforme—Azathioprine—systemic lupus erythematosus	0.000565	0.00787	CcSEcCtD
Chlorpropamide—Fluid retention—Prednisone—systemic lupus erythematosus	0.000544	0.00758	CcSEcCtD
Chlorpropamide—Erythema multiforme—Leflunomide—systemic lupus erythematosus	0.000533	0.00743	CcSEcCtD
Chlorpropamide—Pancytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000504	0.00702	CcSEcCtD
Chlorpropamide—PTGS1—tendon—systemic lupus erythematosus	0.000504	0.00743	CbGeAlD
Chlorpropamide—Vomiting—Dapsone—systemic lupus erythematosus	0.000477	0.00665	CcSEcCtD
Chlorpropamide—Headache—Dapsone—systemic lupus erythematosus	0.00047	0.00655	CcSEcCtD
Chlorpropamide—Leukopenia—Azathioprine—systemic lupus erythematosus	0.000466	0.00648	CcSEcCtD
Chlorpropamide—Aplastic anaemia—Methotrexate—systemic lupus erythematosus	0.00045	0.00627	CcSEcCtD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000448	0.00953	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL21—systemic lupus erythematosus	0.000447	0.00952	CbGpPWpGaD
Chlorpropamide—Nausea—Dapsone—systemic lupus erythematosus	0.000446	0.00621	CcSEcCtD
Chlorpropamide—PTGS1—lung—systemic lupus erythematosus	0.000442	0.00652	CbGeAlD
Chlorpropamide—Agranulocytosis—Mycophenolate mofetil—systemic lupus erythematosus	0.000442	0.00615	CcSEcCtD
Chlorpropamide—Leukopenia—Leflunomide—systemic lupus erythematosus	0.00044	0.00612	CcSEcCtD
Chlorpropamide—Gliclazide—ALB—systemic lupus erythematosus	0.00043	0.114	CrCbGaD
Chlorpropamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.000427	0.0091	CbGpPWpGaD
Chlorpropamide—ABCB1—nephron tubule—systemic lupus erythematosus	0.00042	0.00619	CbGeAlD
Chlorpropamide—Thrombocytopenia—Azathioprine—systemic lupus erythematosus	0.000416	0.00579	CcSEcCtD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000416	0.00885	CbGpPWpGaD
Chlorpropamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NR3C1—systemic lupus erythematosus	0.000414	0.00882	CbGpPWpGaD
Chlorpropamide—PTGS1—nervous system—systemic lupus erythematosus	0.000409	0.00604	CbGeAlD
Chlorpropamide—PTGS1—central nervous system—systemic lupus erythematosus	0.000394	0.00581	CbGeAlD
Chlorpropamide—Thrombocytopenia—Leflunomide—systemic lupus erythematosus	0.000392	0.00547	CcSEcCtD
Chlorpropamide—Anorexia—Leflunomide—systemic lupus erythematosus	0.000382	0.00532	CcSEcCtD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—CRP—systemic lupus erythematosus	0.000382	0.00813	CbGpPWpGaD
Chlorpropamide—PTGS1—Prostaglandin Synthesis and Regulation—PRL—systemic lupus erythematosus	0.000376	0.008	CbGpPWpGaD
Chlorpropamide—ABCB1—kidney—systemic lupus erythematosus	0.000369	0.00544	CbGeAlD
Chlorpropamide—Dermatitis exfoliative—Methotrexate—systemic lupus erythematosus	0.000369	0.00513	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.000366	0.0051	CcSEcCtD
Chlorpropamide—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000359	0.0053	CbGeAlD
Chlorpropamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000358	0.00763	CbGpPWpGaD
Chlorpropamide—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000353	0.00491	CcSEcCtD
Chlorpropamide—Decreased appetite—Leflunomide—systemic lupus erythematosus	0.000348	0.00485	CcSEcCtD
Chlorpropamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—systemic lupus erythematosus	0.000348	0.0074	CbGpPWpGaD
Chlorpropamide—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000346	0.00482	CcSEcCtD
Chlorpropamide—Leukopenia—Cyclosporine—systemic lupus erythematosus	0.000339	0.00473	CcSEcCtD
Chlorpropamide—Leukopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000331	0.00461	CcSEcCtD
Chlorpropamide—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000327	0.00696	CbGpPWpGaD
Chlorpropamide—Urticaria—Leflunomide—systemic lupus erythematosus	0.000318	0.00444	CcSEcCtD
Chlorpropamide—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000317	0.00467	CbGeAlD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000308	0.00657	CbGpPWpGaD
Chlorpropamide—Thrombocytopenia—Cyclosporine—systemic lupus erythematosus	0.000303	0.00422	CcSEcCtD
Chlorpropamide—Eosinophilia—Methotrexate—systemic lupus erythematosus	0.000298	0.00415	CcSEcCtD
Chlorpropamide—ABCC8—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	0.000298	0.00634	CbGpPWpGaD
Chlorpropamide—KCNJ11—Type II diabetes mellitus—TNF—systemic lupus erythematosus	0.000297	0.00632	CbGpPWpGaD
Chlorpropamide—Thrombocytopenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000295	0.00412	CcSEcCtD
Chlorpropamide—Anorexia—Cyclosporine—systemic lupus erythematosus	0.000295	0.00411	CcSEcCtD
Chlorpropamide—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.00029	0.00405	CcSEcCtD
Chlorpropamide—KCNJ11—FOXA2 and FOXA3 transcription factor networks—ALB—systemic lupus erythematosus	0.000289	0.00615	CbGpPWpGaD
Chlorpropamide—ABCB1—bone marrow—systemic lupus erythematosus	0.000288	0.00426	CbGeAlD
Chlorpropamide—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000288	0.00401	CcSEcCtD
Chlorpropamide—ABCB1—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000287	0.00611	CbGpPWpGaD
Chlorpropamide—Pancytopenia—Methotrexate—systemic lupus erythematosus	0.000286	0.00398	CcSEcCtD
Chlorpropamide—Pruritus—Leflunomide—systemic lupus erythematosus	0.000284	0.00395	CcSEcCtD
Chlorpropamide—Dizziness—Azathioprine—systemic lupus erythematosus	0.000281	0.00391	CcSEcCtD
Chlorpropamide—Probenecid—ALB—systemic lupus erythematosus	0.000277	0.0735	CrCbGaD
Chlorpropamide—Photosensitivity reaction—Methotrexate—systemic lupus erythematosus	0.000274	0.00382	CcSEcCtD
Chlorpropamide—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000274	0.00382	CcSEcCtD
Chlorpropamide—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000272	0.00379	CcSEcCtD
Chlorpropamide—Vomiting—Azathioprine—systemic lupus erythematosus	0.00027	0.00376	CcSEcCtD
Chlorpropamide—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000269	0.00375	CcSEcCtD
Chlorpropamide—Rash—Azathioprine—systemic lupus erythematosus	0.000268	0.00373	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000267	0.00372	CcSEcCtD
Chlorpropamide—Headache—Azathioprine—systemic lupus erythematosus	0.000266	0.0037	CcSEcCtD
Chlorpropamide—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000266	0.0037	CcSEcCtD
Chlorpropamide—Dizziness—Leflunomide—systemic lupus erythematosus	0.000265	0.00369	CcSEcCtD
Chlorpropamide—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000262	0.00365	CcSEcCtD
Chlorpropamide—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000262	0.00365	CcSEcCtD
Chlorpropamide—ABCB1—lung—systemic lupus erythematosus	0.000261	0.00386	CbGeAlD
Chlorpropamide—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000261	0.00363	CcSEcCtD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	0.000256	0.00545	CbGpPWpGaD
Chlorpropamide—Vomiting—Leflunomide—systemic lupus erythematosus	0.000255	0.00355	CcSEcCtD
Chlorpropamide—Rash—Leflunomide—systemic lupus erythematosus	0.000253	0.00352	CcSEcCtD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000253	0.00538	CbGpPWpGaD
Chlorpropamide—Nausea—Azathioprine—systemic lupus erythematosus	0.000252	0.00351	CcSEcCtD
Chlorpropamide—Headache—Leflunomide—systemic lupus erythematosus	0.000251	0.0035	CcSEcCtD
Chlorpropamide—Agranulocytosis—Methotrexate—systemic lupus erythematosus	0.00025	0.00348	CcSEcCtD
Chlorpropamide—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000246	0.00342	CcSEcCtD
Chlorpropamide—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000242	0.00337	CcSEcCtD
Chlorpropamide—ABCB1—nervous system—systemic lupus erythematosus	0.000242	0.00357	CbGeAlD
Chlorpropamide—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.00024	0.00334	CcSEcCtD
Chlorpropamide—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000239	0.00333	CcSEcCtD
Chlorpropamide—Nausea—Leflunomide—systemic lupus erythematosus	0.000238	0.00332	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000237	0.00331	CcSEcCtD
Chlorpropamide—ABCB1—central nervous system—systemic lupus erythematosus	0.000233	0.00344	CbGeAlD
Chlorpropamide—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.00023	0.0032	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.00023	0.0032	CcSEcCtD
Chlorpropamide—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000228	0.00317	CcSEcCtD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000228	0.00485	CbGpPWpGaD
Chlorpropamide—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000228	0.00317	CcSEcCtD
Chlorpropamide—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000227	0.00317	CcSEcCtD
Chlorpropamide—Glyburide—ALB—systemic lupus erythematosus	0.000226	0.0601	CrCbGaD
Chlorpropamide—Anorexia—Betamethasone—systemic lupus erythematosus	0.000224	0.00312	CcSEcCtD
Chlorpropamide—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000224	0.00312	CcSEcCtD
Chlorpropamide—Urticaria—Prednisolone—systemic lupus erythematosus	0.000224	0.00311	CcSEcCtD
Chlorpropamide—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000219	0.00305	CcSEcCtD
Chlorpropamide—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000218	0.00304	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—C4A—systemic lupus erythematosus	0.000218	0.00465	CbGpPWpGaD
Chlorpropamide—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000214	0.00297	CcSEcCtD
Chlorpropamide—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	0.000212	0.00452	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000212	0.00295	CcSEcCtD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000211	0.0045	CbGpPWpGaD
Chlorpropamide—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000207	0.00288	CcSEcCtD
Chlorpropamide—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000207	0.00288	CcSEcCtD
Chlorpropamide—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000206	0.00288	CcSEcCtD
Chlorpropamide—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000206	0.00286	CcSEcCtD
Chlorpropamide—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000205	0.00286	CcSEcCtD
Chlorpropamide—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000205	0.00285	CcSEcCtD
Chlorpropamide—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000204	0.00284	CcSEcCtD
Chlorpropamide—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000204	0.00284	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000203	0.00282	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000203	0.00282	CcSEcCtD
Chlorpropamide—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.0002	0.00278	CcSEcCtD
Chlorpropamide—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000197	0.00274	CcSEcCtD
Chlorpropamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000196	0.00418	CbGpPWpGaD
Chlorpropamide—CYP2C19—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000196	0.00417	CbGpPWpGaD
Chlorpropamide—Rash—Cyclosporine—systemic lupus erythematosus	0.000195	0.00272	CcSEcCtD
Chlorpropamide—Anorexia—Prednisone—systemic lupus erythematosus	0.000195	0.00272	CcSEcCtD
Chlorpropamide—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000195	0.00271	CcSEcCtD
Chlorpropamide—Headache—Cyclosporine—systemic lupus erythematosus	0.000194	0.0027	CcSEcCtD
Chlorpropamide—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000192	0.00267	CcSEcCtD
Chlorpropamide—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000191	0.00407	CbGpPWpGaD
Chlorpropamide—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00019	0.00265	CcSEcCtD
Chlorpropamide—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000189	0.00263	CcSEcCtD
Chlorpropamide—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000188	0.00262	CcSEcCtD
Chlorpropamide—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000188	0.00261	CcSEcCtD
Chlorpropamide—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000187	0.0026	CcSEcCtD
Chlorpropamide—Urticaria—Betamethasone—systemic lupus erythematosus	0.000187	0.0026	CcSEcCtD
Chlorpropamide—Dizziness—Prednisolone—systemic lupus erythematosus	0.000186	0.00259	CcSEcCtD
Chlorpropamide—Nausea—Cyclosporine—systemic lupus erythematosus	0.000184	0.00256	CcSEcCtD
Chlorpropamide—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000183	0.00255	CcSEcCtD
Chlorpropamide—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000183	0.00255	CcSEcCtD
Chlorpropamide—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000182	0.00253	CcSEcCtD
Chlorpropamide—Dyspepsia—Prednisone—systemic lupus erythematosus	0.00018	0.00251	CcSEcCtD
Chlorpropamide—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000179	0.0025	CcSEcCtD
Chlorpropamide—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000179	0.0038	CbGpPWpGaD
Chlorpropamide—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000178	0.00248	CcSEcCtD
Chlorpropamide—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000178	0.00378	CbGpPWpGaD
Chlorpropamide—Rash—Prednisolone—systemic lupus erythematosus	0.000178	0.00247	CcSEcCtD
Chlorpropamide—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000177	0.00246	CcSEcCtD
Chlorpropamide—Headache—Prednisolone—systemic lupus erythematosus	0.000176	0.00246	CcSEcCtD
Chlorpropamide—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000175	0.00243	CcSEcCtD
Chlorpropamide—Rash—Hydrocortisone—systemic lupus erythematosus	0.000173	0.00241	CcSEcCtD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.000173	0.00368	CbGpPWpGaD
Chlorpropamide—Headache—Hydrocortisone—systemic lupus erythematosus	0.000172	0.0024	CcSEcCtD
Chlorpropamide—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000171	0.00238	CcSEcCtD
Chlorpropamide—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000171	0.00238	CcSEcCtD
Chlorpropamide—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000167	0.00233	CcSEcCtD
Chlorpropamide—Nausea—Prednisolone—systemic lupus erythematosus	0.000167	0.00233	CcSEcCtD
Chlorpropamide—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000166	0.00355	CbGpPWpGaD
Chlorpropamide—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000166	0.00231	CcSEcCtD
Chlorpropamide—Pruritus—Betamethasone—systemic lupus erythematosus	0.000166	0.00231	CcSEcCtD
Chlorpropamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000165	0.00351	CbGpPWpGaD
Chlorpropamide—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000165	0.00229	CcSEcCtD
Chlorpropamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.000164	0.0035	CbGpPWpGaD
Chlorpropamide—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000164	0.00229	CcSEcCtD
Chlorpropamide—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000163	0.00227	CcSEcCtD
Chlorpropamide—Rash—Triamcinolone—systemic lupus erythematosus	0.000163	0.00227	CcSEcCtD
Chlorpropamide—Anorexia—Methotrexate—systemic lupus erythematosus	0.000163	0.00227	CcSEcCtD
Chlorpropamide—Rash—Methylprednisolone—systemic lupus erythematosus	0.000163	0.00227	CcSEcCtD
Chlorpropamide—Urticaria—Prednisone—systemic lupus erythematosus	0.000163	0.00226	CcSEcCtD
Chlorpropamide—Headache—Triamcinolone—systemic lupus erythematosus	0.000162	0.00226	CcSEcCtD
Chlorpropamide—Headache—Methylprednisolone—systemic lupus erythematosus	0.000162	0.00225	CcSEcCtD
Chlorpropamide—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000161	0.00224	CcSEcCtD
Chlorpropamide—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000161	0.00224	CcSEcCtD
Chlorpropamide—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000158	0.00336	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000157	0.00334	CbGpPWpGaD
Chlorpropamide—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000155	0.00216	CcSEcCtD
Chlorpropamide—Dizziness—Betamethasone—systemic lupus erythematosus	0.000155	0.00216	CcSEcCtD
Chlorpropamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000154	0.00328	CbGpPWpGaD
Chlorpropamide—Nausea—Triamcinolone—systemic lupus erythematosus	0.000154	0.00214	CcSEcCtD
Chlorpropamide—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000153	0.00214	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—FOXP3—systemic lupus erythematosus	0.000153	0.00325	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000152	0.00323	CbGpPWpGaD
Chlorpropamide—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.00015	0.0021	CcSEcCtD
Chlorpropamide—Vomiting—Betamethasone—systemic lupus erythematosus	0.000149	0.00208	CcSEcCtD
Chlorpropamide—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000149	0.00208	CcSEcCtD
Chlorpropamide—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000149	0.00207	CcSEcCtD
Chlorpropamide—Rash—Betamethasone—systemic lupus erythematosus	0.000148	0.00206	CcSEcCtD
Chlorpropamide—Rash—Dexamethasone—systemic lupus erythematosus	0.000148	0.00206	CcSEcCtD
Chlorpropamide—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000148	0.00206	CcSEcCtD
Chlorpropamide—Headache—Betamethasone—systemic lupus erythematosus	0.000147	0.00205	CcSEcCtD
Chlorpropamide—Headache—Dexamethasone—systemic lupus erythematosus	0.000147	0.00205	CcSEcCtD
Chlorpropamide—Pruritus—Prednisone—systemic lupus erythematosus	0.000145	0.00202	CcSEcCtD
Chlorpropamide—Diarrhoea—Prednisone—systemic lupus erythematosus	0.00014	0.00195	CcSEcCtD
Chlorpropamide—Nausea—Dexamethasone—systemic lupus erythematosus	0.00014	0.00194	CcSEcCtD
Chlorpropamide—Nausea—Betamethasone—systemic lupus erythematosus	0.00014	0.00194	CcSEcCtD
Chlorpropamide—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	0.000139	0.00297	CbGpPWpGaD
Chlorpropamide—Urticaria—Methotrexate—systemic lupus erythematosus	0.000136	0.00189	CcSEcCtD
Chlorpropamide—Dizziness—Prednisone—systemic lupus erythematosus	0.000135	0.00188	CcSEcCtD
Chlorpropamide—Vomiting—Prednisone—systemic lupus erythematosus	0.00013	0.00181	CcSEcCtD
Chlorpropamide—Rash—Prednisone—systemic lupus erythematosus	0.000129	0.0018	CcSEcCtD
Chlorpropamide—Headache—Prednisone—systemic lupus erythematosus	0.000128	0.00178	CcSEcCtD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000124	0.00265	CbGpPWpGaD
Chlorpropamide—Nausea—Prednisone—systemic lupus erythematosus	0.000122	0.00169	CcSEcCtD
Chlorpropamide—Pruritus—Methotrexate—systemic lupus erythematosus	0.000121	0.00168	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—IL17A—systemic lupus erythematosus	0.00012	0.00256	CbGpPWpGaD
Chlorpropamide—CYP2C19—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000118	0.00252	CbGpPWpGaD
Chlorpropamide—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000118	0.00251	CbGpPWpGaD
Chlorpropamide—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000117	0.00163	CcSEcCtD
Chlorpropamide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000115	0.00245	CbGpPWpGaD
Chlorpropamide—Dizziness—Methotrexate—systemic lupus erythematosus	0.000113	0.00157	CcSEcCtD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000112	0.00238	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL12B—systemic lupus erythematosus	0.000112	0.00238	CbGpPWpGaD
Chlorpropamide—Vomiting—Methotrexate—systemic lupus erythematosus	0.000109	0.00151	CcSEcCtD
Chlorpropamide—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000108	0.0023	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CXCL12—systemic lupus erythematosus	0.000108	0.0023	CbGpPWpGaD
Chlorpropamide—Rash—Methotrexate—systemic lupus erythematosus	0.000108	0.0015	CcSEcCtD
Chlorpropamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000107	0.00229	CbGpPWpGaD
Chlorpropamide—Headache—Methotrexate—systemic lupus erythematosus	0.000107	0.00149	CcSEcCtD
Chlorpropamide—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	0.000107	0.00227	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	0.000105	0.00224	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000103	0.0022	CbGpPWpGaD
Chlorpropamide—Nausea—Methotrexate—systemic lupus erythematosus	0.000102	0.00141	CcSEcCtD
Chlorpropamide—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	9.6e-05	0.00204	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	9.25e-05	0.00197	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	9.21e-05	0.00196	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	9.1e-05	0.00194	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.97e-05	0.00191	CbGpPWpGaD
Chlorpropamide—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	8.84e-05	0.00188	CbGpPWpGaD
Chlorpropamide—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.75e-05	0.00186	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	8.65e-05	0.00184	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	8.58e-05	0.00183	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	8.29e-05	0.00177	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.18e-05	0.00174	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	8.17e-05	0.00174	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	8.17e-05	0.00174	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	7.95e-05	0.00169	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	7.83e-05	0.00167	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	7.6e-05	0.00162	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	7.51e-05	0.0016	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	7.32e-05	0.00156	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	7.28e-05	0.00155	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	7.22e-05	0.00154	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	7.14e-05	0.00152	CbGpPWpGaD
Chlorpropamide—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.8e-05	0.00145	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	6.58e-05	0.0014	CbGpPWpGaD
Chlorpropamide—SLC15A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6.47e-05	0.00138	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	6.43e-05	0.00137	CbGpPWpGaD
Chlorpropamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	6.39e-05	0.00136	CbGpPWpGaD
Chlorpropamide—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.2e-05	0.00132	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	6.08e-05	0.00129	CbGpPWpGaD
Chlorpropamide—SLC15A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	6e-05	0.00128	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.79e-05	0.00123	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	5.54e-05	0.00118	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.37e-05	0.00114	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—NAT2—systemic lupus erythematosus	5.37e-05	0.00114	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	5.22e-05	0.00111	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—NAT2—systemic lupus erythematosus	5.21e-05	0.00111	CbGpPWpGaD
Chlorpropamide—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	5.1e-05	0.00109	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	5.07e-05	0.00108	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	4.8e-05	0.00102	CbGpPWpGaD
Chlorpropamide—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	4.65e-05	0.00099	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	4.58e-05	0.000974	CbGpPWpGaD
Chlorpropamide—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	4.46e-05	0.000949	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	4.42e-05	0.000942	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	4.27e-05	0.000909	CbGpPWpGaD
Chlorpropamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.19e-05	0.000892	CbGpPWpGaD
Chlorpropamide—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4.09e-05	0.000871	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.99e-05	0.00085	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	3.75e-05	0.000798	CbGpPWpGaD
Chlorpropamide—ABCC8—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.65e-05	0.000778	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	3.63e-05	0.000773	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	3.61e-05	0.00077	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.4e-05	0.000723	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.33e-05	0.000709	CbGpPWpGaD
Chlorpropamide—SLC15A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.29e-05	0.0007	CbGpPWpGaD
Chlorpropamide—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.11e-05	0.000662	CbGpPWpGaD
Chlorpropamide—SLC15A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.05e-05	0.00065	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—RXRA—systemic lupus erythematosus	3.01e-05	0.000641	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—RXRA—systemic lupus erythematosus	2.92e-05	0.000622	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	2.7e-05	0.000574	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.27e-05	0.000484	CbGpPWpGaD
Chlorpropamide—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.27e-05	0.000482	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.15e-05	0.000458	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.14e-05	0.000457	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.99e-05	0.000423	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.96e-05	0.000417	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.93e-05	0.000411	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PPARG—systemic lupus erythematosus	1.9e-05	0.000405	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.89e-05	0.000403	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PPARG—systemic lupus erythematosus	1.84e-05	0.000393	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.82e-05	0.000387	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.79e-05	0.000381	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.79e-05	0.00038	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—ALB—systemic lupus erythematosus	1.71e-05	0.000364	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.69e-05	0.000359	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—ALB—systemic lupus erythematosus	1.66e-05	0.000353	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.64e-05	0.00035	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—NOS3—systemic lupus erythematosus	1.64e-05	0.000348	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—NOS3—systemic lupus erythematosus	1.59e-05	0.000338	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.56e-05	0.000331	CbGpPWpGaD
Chlorpropamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.53e-05	0.000327	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.52e-05	0.000323	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.51e-05	0.000322	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—PTGS2—systemic lupus erythematosus	1.5e-05	0.000319	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—PTGS2—systemic lupus erythematosus	1.45e-05	0.000309	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.42e-05	0.000302	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.4e-05	0.000299	CbGpPWpGaD
Chlorpropamide—ABCC8—Metabolism—EP300—systemic lupus erythematosus	1.24e-05	0.000265	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.24e-05	0.000263	CbGpPWpGaD
Chlorpropamide—KCNJ11—Metabolism—EP300—systemic lupus erythematosus	1.21e-05	0.000257	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.13e-05	0.00024	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.11e-05	0.000237	CbGpPWpGaD
Chlorpropamide—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.03e-05	0.00022	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.01e-05	0.000216	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.73e-06	0.000207	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	9.55e-06	0.000203	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.87e-06	0.000189	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	8.72e-06	0.000186	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—ALB—systemic lupus erythematosus	8.59e-06	0.000183	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	8.51e-06	0.000181	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	8.21e-06	0.000175	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.09e-06	0.000172	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	7.95e-06	0.000169	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	7.51e-06	0.00016	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.38e-06	0.000157	CbGpPWpGaD
Chlorpropamide—PTGS1—Metabolism—EP300—systemic lupus erythematosus	6.25e-06	0.000133	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	5.51e-06	0.000117	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	5.37e-06	0.000114	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.02e-06	0.000107	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	4.95e-06	0.000105	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—ALB—systemic lupus erythematosus	4.83e-06	0.000103	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	4.74e-06	0.000101	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.62e-06	9.84e-05	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	4.51e-06	9.61e-05	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	4.33e-06	9.22e-05	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.32e-06	9.19e-05	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.23e-06	9e-05	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	3.95e-06	8.41e-05	CbGpPWpGaD
Chlorpropamide—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	3.6e-06	7.67e-05	CbGpPWpGaD
Chlorpropamide—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.52e-06	7.49e-05	CbGpPWpGaD
Chlorpropamide—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.28e-06	6.99e-05	CbGpPWpGaD
